CNVIF OTC
Conavi Medical Corp.
1W: +6.4%
1M: -16.7%
3M: -30.2%
YTD: -68.3%
$0.11
+0.00 (+2.23%)
Weekly Expected Move ±12.8%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$9.4M
52W Range0.1-0.555
Volume11,193
Avg Volume29,827
Beta0.57
Dividend—
Analyst Ratings
Company Info
CEOThomas Looby
Employees4
SectorHealthcare
IndustryMedical - Devices
IPO Date2024-10-14
Websiteconavi.com/novasight
293 Lesmill Road
Toronto, ON M3B 2V1
CA
Toronto, ON M3B 2V1
CA
1 416-483-0100
About Conavi Medical Corp.
Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Latest News
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Recent Insider Trades
No insider trades found